...
首页> 外文期刊>Virology >A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.
【24h】

A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.

机译:融合至整合酶(IN)的新型Vpr肽相互作用物可恢复对IN缺陷型HIV-1病毒体的整合活性。

获取原文
获取原文并翻译 | 示例

摘要

A novel approach to complement human immunodeficiency virus type I (HIV-1) integrase (IN)-defective virions has been identified. The approach involves fusion of a 23-amino-acid stretch to the N-terminus of wild-type IN and coexpression of this chimera with the IN-defective proviral template in virus producing cells. The 23-amino-acid peptide represents a Vpr "interactor," referred to as the the WxxF or WF domain, which apparently leads to docking of the domain along with the fusion partner onto HIV-1 Vpr, thus permitting virion incorporation of the chimeric protein when expressed, in trans, with other viral products. Transfection of the WF-IN expression plasmid along with HIV-1 viral clones that produce Vpr, but bear an IN mutation, results in the release of a proportion of viral particles that are competent for integration. The extent of complementation was assessed using the MAGI cell assay, where integration of viral DNA results in the eventual appearance of easily visible multinucleated blue syncytia. The efficiency of dWF-IN (double copy of WF domain) complementation is not improved markedly by incorporation of a HIV-1 protease cleavage site (PR) between the dWF domain and IN (dWF-PR-IN), unlike that observed with Vpr fusions to IN. Furthermore, the ability of Vpr-PR-IN and dWF-PR-IN to complement IN-defective proviral clones, both of which bear an intervening protease cleavage site, appear comparable. Western blotting analyses using virions isolated through sucrose cushions demonstrate clearly the incorporation of the dWF-IN fusion protein into Vpr containing HIV-1 particles but not in Vpr-deficient virions. Additional Western blotting analyses indicate that all Vpr-IN and dWF-IN chimeras, with or without a PR site, are packaged into virions. The efficiency of virion incorporation of Vpr-IN and dWF-IN chimeras appears approximately comparable by Western blotting analysis. The ability of dWF-IN to complement IN-defective proviruses with efficiency similar to that of Vpr-PR-IN and dWF-PR-IN indicates that dWF-IN retains the full complement of functions necessary for integration of proviral DNA and is likely due to the benign nature of this small domain at the amino-terminus of IN. Copyright 1999 Academic Press.
机译:已经确定了一种补充人免疫缺陷病毒I型(HIV-1)整合酶(IN)缺陷病毒体的新方法。该方法涉及在野生型IN的N末端融合一个23个氨基酸的片段,并在产生病毒的细胞中将该嵌合体与IN缺陷型前病毒模板共表达。 23个氨基酸的肽代表一个Vpr“相互作用体”,称为WxxF或WF结构域,显然会导致该结构域与融合伴侣一起停靠在HIV-1 Vpr上,从而允许嵌合体的病毒体掺入反式表达时与其他病毒产物表达蛋白质。 WF-IN表达质粒与产生Vpr但带有IN突变的HIV-1病毒克隆一起转染,导致一定比例的病毒颗粒能够整合。使用MAGI细胞测定法评估互补的程度,其中病毒DNA的整合导致最终出现易于看见的多核蓝色合胞体。通过在dWF域和IN之间掺入HIV-1蛋白酶切割位点(PR),与使用Vpr观察到的dWF-IN(WF域的双拷贝)互补效率没有显着提高。与IN融合。此外,Vpr-PR-IN和dWF-PR-IN互补IN缺陷型前病毒克隆的能力似乎是可比的,这两个克隆均具有中间蛋白酶切割位点。使用通过蔗糖垫分离的病毒体的蛋白质印迹分析清楚地表明,dWF-IN融合蛋白已掺入含有Vpr的HIV-1颗粒中,但未掺入缺乏Vpr的病毒体中。其他Western印迹分析表明,所有带有或不带有PR位点的Vpr-IN和dWF-IN嵌合体都包装在病毒体中。通过蛋白质印迹分析,病毒体掺入Vpr-IN和dWF-IN嵌合体的效率似乎相当。 dWF-IN以类似于Vpr-PR-IN和dWF-PR-IN的效率补充IN缺陷前病毒的能力表明dWF-IN保留了整合前病毒DNA所需的全部功能,这很可能是由于在IN的氨基末端具有这个小结构域的良性。版权所有1999,学术出版社。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号